Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,237 public trials 1,175 recruiting studies

Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Active, Not Recruiting

Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study)

NCT05537701

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: CHU de Liege Liège, Belgium

View Trial Details

Active, Not Recruiting

Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer

NCT03066297

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Active, Not Recruiting

Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

NCT04379739

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Shanghai Pulmonary Hospital Shang'ai, Shanghai Municipality, China

View Trial Details

Active, Not Recruiting

Quest for Tumour Evolution of Non-small Cell Lung Cancer

NCT05811169

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Department of Clinical Oncology, Queen Mary Hospital Hong Kong

View Trial Details

Active, Not Recruiting

Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC)

NCT05784142

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Jiangsu Cancer Hospital Nanjing, Jiangsu, China

View Trial Details

Active, Not Recruiting

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

NCT03836352

Conditions: Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +39 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

Cedars Sinai Medical Center: Samuel Oschin Comprehensive Cancer Center Los Angeles, California, United States

Boca Raton Regional Hospital, Lynn Cancer Institute Boca Raton, Florida, United States

Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States

View all 23 locations

View Trial Details

Active, Not Recruiting

Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung Cancer

NCT04304248

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Sun Yat sen University cancer center Guangzhou, Guangdong, China

View Trial Details

Bronchial Neoplasms

Bronchial Neoplasms trial results

Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study)

Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer

Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

Quest for Tumour Evolution of Non-small Cell Lung Cancer

Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC)

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung Cancer

Related conditions